Glucagon and Advanced HCL System to Prevent Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

May 13, 2024

Study Completion Date

May 13, 2024

Conditions

Type 1 DiabetesHypoglycemia

Interventions

DRUG

GlucaGen

150 ug glucagon will be administered to the participants before exercise.

Trial Locations (1)

Steno Diabetes Center Copenhagen, Herlev

All Listed Sponsors

lead

Steno Diabetes Center Copenhagen

OTHER